Moreover, increased plasma levels of LIF were detected in patients with multiple cancer types, e.g., prostate cancer, bladder cancer, ureteral cancer, non-small cell lung cancer, colorectal cancer, and renal cancer (Fig. 2g). Here, LIF is linked to renal carcinoma.